Partners Innovation is a venture capital firm in Boston that prefers to focus on innovations in medical systems, therapy, drugs, and medical devices. Founded in 2007 in Boston, Massachusetts, the firm invests in debt, early stage ventures and seed stages. This firm usually invests in series A, series B, and series D rounds. The notable investment portfolio of Partners Innovation includes ZielBio, Triplet Therapeutics, Akouos, Sebacia, Syntimmune, etc. As of January 2020, Partners Innovation has made 32 investments and 9 exits; and is actively looking for new investment opportunities.
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.
A clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens
Akouos is a Brookline, Massachusetts-based biotechnology company developing precision genetics-based medicines founded in 2016 by Emmanuel Simons.
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
Sebacia is a Duluth, Georgia-based company.
Chief Innovation Officer / Partners HealthCare
Managing Director / Administration / Strategy
Director / Business Development
Patrick Fortune, PhD
Vice President / Market Sectors
Vice President / Operations
Vice President / Venture
Seema Basu, PhD
Market Sector Leader
Vice President / Business Development
Documentaries, videos and podcasts